07.01.2026 • News

Mike Radossich Assumes Role of Syensqo CEO

Seasoned Syensqo business leader to guide the company’s next chapter.

Mike Radossich
Mike Radossich, CEO, Syensqo
© Syensqo

Syensqo recently announced that, further to the announcement made last fall, Mike Radossich has officially assumed the role of Chief Executive Officer and member of the Board of Directors. Mike succeeds Ilham Kadri, who will continue supporting the company as a special advisor to ensure a smooth transition of leadership. These changes are effective from January 1, 2026.

A long-standing Syensqo executive with extensive experience leading global businesses, Mike brings deep industry knowledge and a strong track record of operational excellence. He will steer Syensqo’s next phase as the company continues to focus on creating value for its stakeholders, accelerating sustainable, profitable growth, and driving long-term performance.

Company

Syensqo

rue de la Fusée 98
B-1130 Brussels
Belgium

Company contact







Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.